Annual Total Liabilities
$36.13 M
-$2.18 M-5.68%
31 December 2023
Summary:
Capricor Therapeutics annual total liabilities is currently $36.13 million, with the most recent change of -$2.18 million (-5.68%) on 31 December 2023. During the last 3 years, it has risen by +$26.17 million (+262.69%). CAPR annual total liabilities is now -5.68% below its all-time high of $38.31 million, reached on 31 December 2022.CAPR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$24.69 M
-$2.09 M-7.80%
30 September 2024
Summary:
Capricor Therapeutics quarterly total liabilities is currently $24.69 million, with the most recent change of -$2.09 million (-7.80%) on 30 September 2024. Over the past year, it has dropped by -$11.45 million (-31.68%). CAPR quarterly total liabilities is now -48.20% below its all-time high of $47.66 million, reached on 31 March 2023.CAPR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CAPR Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -31.7% |
| 3 y3 years | +262.7% | +147.8% |
| 5 y5 years | +745.4% | +477.6% |
CAPR Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -5.7% | +262.7% | -48.2% | +147.8% |
| 5 y | 5 years | -5.7% | +745.4% | -48.2% | +477.6% |
| alltime | all time | -5.7% | >+9999.0% | -48.2% | >+9999.0% |
Capricor Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $24.69 M(-7.8%) |
| June 2024 | - | $26.78 M(-13.7%) |
| Mar 2024 | - | $31.01 M(-14.2%) |
| Dec 2023 | $36.13 M(-5.7%) | $36.13 M(-7.2%) |
| Sept 2023 | - | $38.94 M(-10.0%) |
| June 2023 | - | $43.28 M(-9.2%) |
| Mar 2023 | - | $47.66 M(+24.4%) |
| Dec 2022 | $38.31 M(+284.5%) | $38.31 M(-0.5%) |
| Sept 2022 | - | $38.50 M(-2.1%) |
| June 2022 | - | $39.34 M(-2.3%) |
| Mar 2022 | - | $40.28 M(+304.3%) |
| Dec 2021 | $9.96 M(+55.2%) | $9.96 M(+56.5%) |
| Sept 2021 | - | $6.36 M(-2.8%) |
| June 2021 | - | $6.55 M(-8.6%) |
| Mar 2021 | - | $7.16 M(+11.6%) |
| Dec 2020 | $6.42 M(+50.2%) | $6.42 M(+11.1%) |
| Sept 2020 | - | $5.78 M(+5.6%) |
| June 2020 | - | $5.47 M(+16.4%) |
| Mar 2020 | - | $4.70 M(+10.0%) |
| Dec 2019 | $4.27 M(-7.7%) | $4.27 M(-1.4%) |
| Sept 2019 | - | $4.34 M(-12.3%) |
| June 2019 | - | $4.94 M(+1.4%) |
| Mar 2019 | - | $4.88 M(+5.3%) |
| Dec 2018 | $4.63 M(-8.2%) | $4.63 M(-11.8%) |
| Sept 2018 | - | $5.25 M(+11.8%) |
| June 2018 | - | $4.70 M(-3.3%) |
| Mar 2018 | - | $4.85 M(-3.8%) |
| Dec 2017 | $5.05 M(-77.8%) | $5.05 M(-74.8%) |
| Sept 2017 | - | $20.06 M(-3.6%) |
| June 2017 | - | $20.80 M(-2.1%) |
| Mar 2017 | - | $21.26 M(-6.6%) |
| Dec 2016 | $22.75 M(+33.0%) | $22.75 M(-6.8%) |
| Sept 2016 | - | $24.42 M(+28.5%) |
| June 2016 | - | $19.01 M(+5.2%) |
| Mar 2016 | - | $18.07 M(+5.7%) |
| Dec 2015 | $17.10 M(-14.0%) | $17.10 M(-4.8%) |
| Sept 2015 | - | $17.96 M(-6.2%) |
| June 2015 | - | $19.14 M(-5.0%) |
| Mar 2015 | - | $20.15 M(+1.3%) |
| Dec 2014 | $19.88 M(+227.4%) | $19.88 M(-4.2%) |
| Sept 2014 | - | $20.75 M(-3.6%) |
| June 2014 | - | $21.52 M(+22.0%) |
| Mar 2014 | - | $17.64 M(+190.4%) |
| Dec 2013 | $6.07 M(+1047.5%) | $6.07 M(+261.1%) |
| Sept 2013 | - | $1.68 M(+10.1%) |
| June 2013 | - | $1.53 M(+44.4%) |
| Mar 2013 | - | $1.06 M(+99.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $529.20 K(-2.3%) | $529.20 K(+13.1%) |
| Sept 2012 | - | $468.00 K(+2.2%) |
| June 2012 | - | $457.90 K(-5.6%) |
| Mar 2012 | - | $485.30 K(-10.4%) |
| Dec 2011 | $541.40 K(-49.4%) | $541.40 K(-24.6%) |
| Sept 2011 | - | $717.80 K(+64.5%) |
| June 2011 | - | $436.30 K(-41.3%) |
| Mar 2011 | - | $743.70 K(-30.4%) |
| Dec 2010 | $1.07 M(+67.7%) | $1.07 M(-28.9%) |
| Sept 2010 | - | $1.50 M(+30.9%) |
| June 2010 | - | $1.15 M(+29.3%) |
| Mar 2010 | - | $889.20 K(+39.5%) |
| Dec 2009 | $637.60 K(-52.1%) | $637.60 K(-24.5%) |
| Sept 2009 | - | $844.90 K(+91.8%) |
| June 2009 | - | $440.40 K(-43.4%) |
| Mar 2009 | - | $778.40 K(-41.6%) |
| Dec 2008 | $1.33 M(-29.5%) | $1.33 M(+45.1%) |
| Sept 2008 | - | $918.10 K(-8.1%) |
| June 2008 | - | $999.50 K(-27.5%) |
| Mar 2008 | - | $1.38 M(-27.0%) |
| Dec 2007 | $1.89 M(+1301.6%) | $1.89 M(+39.2%) |
| Sept 2007 | - | $1.36 M(+707.2%) |
| June 2007 | - | $168.10 K(+15.9%) |
| Mar 2007 | - | $145.10 K(+7.6%) |
| Dec 2006 | $134.80 K(+73.0%) | $134.80 K(+7.8%) |
| Sept 2006 | - | $125.00 K(+38.6%) |
| June 2006 | - | $90.20 K(+8.4%) |
| Mar 2006 | - | $83.20 K(+6.8%) |
| Dec 2005 | $77.90 K(+31.1%) | $77.90 K(+5.7%) |
| Sept 2005 | - | $73.70 K(+9.7%) |
| June 2005 | - | $67.20 K(+0.3%) |
| Mar 2005 | - | $67.00 K(+12.8%) |
| Dec 2004 | $59.40 K(+42.1%) | $59.40 K(+17.9%) |
| Sept 2004 | - | $50.40 K(+1.6%) |
| June 2004 | - | $49.60 K(-4.2%) |
| Mar 2004 | - | $51.80 K(+23.9%) |
| Dec 2003 | $41.80 K(+69.9%) | $41.80 K(+18.4%) |
| Sept 2003 | - | $35.30 K(+0.3%) |
| June 2003 | - | $35.20 K(+24.4%) |
| Mar 2003 | - | $28.30 K(+15.0%) |
| Dec 2002 | $24.60 K(+167.4%) | $24.60 K(+17.7%) |
| Sept 2002 | - | $20.90 K(+68.5%) |
| June 2002 | - | $12.40 K(+39.3%) |
| Mar 2002 | - | $8900.00(-3.3%) |
| Dec 2001 | $9200.00(+922.2%) | $9200.00 |
| Dec 2000 | $900.00(0.0%) | - |
| Dec 1999 | $900.00 | - |
FAQ
- What is Capricor Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly total liabilities year-on-year change?
What is Capricor Therapeutics annual total liabilities?
The current annual total liabilities of CAPR is $36.13 M
What is the all time high annual total liabilities for Capricor Therapeutics?
Capricor Therapeutics all-time high annual total liabilities is $38.31 M
What is Capricor Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CAPR is $24.69 M
What is the all time high quarterly total liabilities for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly total liabilities is $47.66 M
What is Capricor Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CAPR quarterly total liabilities has changed by -$11.45 M (-31.68%)